title: Alendronate versus calcitriol for prevention of bone loss after cardiac transplantation.
authors.forename: Agnès
authors.initials: A
authors.lastname: Dejardin
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Devogelaer
authors.forename: Eric
authors.initials: E
authors.lastname: Goffin
mesh_terms: D019386:Alendronate / Q000627:therapeutic use*; D015519:Bone Density; D001862:Bone Resorption / Q000517:prevention & control*; D002117:Calcitriol / Q000627:therapeutic use*; D003404:Creatinine / Q000378:metabolism; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D016027:Heart Transplantation; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D051437:Renal Insufficiency; D016559:Tacrolimus / Q000627:therapeutic use
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine; D002117:Calcitriol; D011241:Prednisone; D016559:Tacrolimus; D019386:Alendronate